The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
about
Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt SignallingAdvance Care Planning in Glioblastoma PatientsGlioblastoma, hypoxia and autophagy: a survival-prone 'ménage-à-trois'The therapeutic potential of targeting the PI3K pathway in pediatric brain tumorsTargeting immune checkpoints in malignant gliomaThe prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients' survival: a meta-analysisA Comparative Study of the Molecular Characteristics of Familial Gliomas and Other CancersDNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery.Brain tumor classification using AFM in combination with data mining techniques.Non-invasive metabolic imaging of brain tumours in the era of precision medicine.MRI-guided laser interstitial thermal therapy for the treatment of low-grade gliomas in children: a case-series review, description of the current technologies and perspectives.Detecting tumor progression in glioma: Current standards and new techniques.Recent advances in subtyping tumors of the central nervous system using molecular data.Clinicopathological differences between variants of the NAB2-STAT6 fusion gene in solitary fibrous tumors of the meninges and extra-central nervous system.Meningeal haemangiopericytoma and solitary fibrous tumour: a retrospective bi centre study for outcome and prognostic factor assessment.The McGill Interactive Pediatric OncoGenetic Guidelines: An approach to identifying pediatric oncology patients most likely to benefit from a genetic evaluation.Metabotropic glutamate receptors as a new therapeutic target for malignant gliomasDifferential expression of folate receptor 1 in medulloblastoma and the correlation with clinicopathological characters and target therapeutic potentialAcid ceramidase is a novel drug target for pediatric brain tumors.Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategyMultidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.Molecular Testing of Brain Tumor.RIZ1 negatively regulates ubiquitin-conjugating enzyme E2C/UbcH10 via targeting c-Myc in meningioma.IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRIExpression of Cathepsins B, D, and G in Isocitrate Dehydrogenase-Wildtype Glioblastoma.Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas.Single vs. combination immunotherapeutic strategies for glioma.Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET.Rexin-G®, a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report.Actionable molecular biomarkers in primary brain tumors.Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.Fluorescence Lifetime Imaging Microscopy, a Novel Diagnostic Tool for Metastatic Cell Detection in the Cerebrospinal Fluid of Children with MedulloblastomaProspective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant GliomaImmunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival.Genetic landscape of extreme responders with anaplastic oligodendroglioma.The Expression of Connexins and SOX2 Reflects the Plasticity of Glioma Stem-Like Cells.Does early resection of presumed low-grade glioma improve survival? A clinical perspective.Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases.Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas.PET Imaging in Patients with Meningioma - Report of the RANO/PET Group.
P2860
Q26739662-606D501E-6A37-4DF0-AFD1-6EF8122AA277Q28067320-BE0CC7E6-B6DD-4DAF-A7FA-3FAF1820223CQ28067399-F6DE4048-C196-4D1D-BAF9-083FD25D6973Q28070264-1B1027DB-B694-4529-AC06-0AF260F0FEFDQ28072012-8A97C6E6-EF15-4952-A757-0FADFAF668EAQ28074595-2804085A-5AE0-4D04-A03B-333CAA196201Q29248470-C1CA9846-1E29-4975-9B46-AA3FC630ED20Q30359384-4A7E11D9-1C04-427B-BB14-AA55F0F4B64BQ30669767-B8C14DCB-D345-4B7B-8006-760A6C2E52B6Q31115540-FAF07104-C8B1-4683-B13C-5B8E47C532E5Q31132623-C56AF765-0ABD-4FFF-8B68-453068D8EC3EQ31132701-DA5BECE5-83A6-4A43-B8E0-956174EA0DE3Q31145092-61B4C78E-28D4-4CFD-A9B0-8499E2146199Q33432852-0AD3032C-E87B-41FC-848D-99ADBF0A4087Q33443494-1E9B1593-C9E3-4ACB-839A-D04BC61B7875Q33452301-99AF87B0-FAC8-407F-BC1A-82007CDC605BQ33591900-7CFA35F4-7B84-4563-B126-9C283512D841Q33618570-C4E54EDB-BE0F-498F-B8D6-16E12C929DDBQ33648644-4CF4C5ED-37F1-4B23-8D45-DAA340BCE6A7Q33683101-FC2E7ACF-7D44-4485-ABA6-826B2E135805Q33711322-4CF2421A-7042-4FDD-A389-3FE57363C78BQ33729693-1D236A94-4AB7-415F-917B-BB8FAD472DDCQ33733305-CFF5B905-B548-4494-AFF0-A84B8B031F7EQ33733375-2F044F34-8D37-4213-A433-6240255F5AF6Q33734645-0C1F7588-CA98-4534-A686-EBBB81534F22Q33737472-3E66F041-D55E-4DFD-9F0F-E0F659EA446AQ33746041-7DE35F6D-EF90-4653-9928-8AA30F47A288Q33746805-296BAAE5-1AE5-491E-B411-AE16C4F5B32EQ33748342-7C83EC56-9CAC-4DAF-9CF6-73CA4D64E0FCQ33772355-4460D663-8E6A-4A3E-B8A4-FD36072041EAQ33803137-9F7B6EAD-71F7-42A3-ADA1-0B1E14E7FEE3Q33807896-D9B11162-09C8-4BBB-8292-C5F1DC516446Q33816600-3CB7E367-8015-4F1D-956A-8CFE44B10E01Q33823230-883F1E31-5194-47CB-99BE-FAE334A169A0Q33829209-57269DCF-BAA8-4F0E-B571-08442FD36D03Q33842621-BE8A0ADF-5693-4EAD-8B35-D4306CEC3158Q33867304-84CF54D5-8519-4994-AB0E-AFC49A6CCD7DQ33891266-F0FF164B-C0EC-46B2-8155-80137662171DQ34552042-9816C0C0-4C0F-4FA4-89AC-74F1176D4E85Q34682187-8728C739-21CF-45CD-A332-2FF3767FDDC9
P2860
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The 2016 World Health Organiza ...... ral Nervous System: a summary.
@en
type
label
The 2016 World Health Organiza ...... ral Nervous System: a summary.
@en
prefLabel
The 2016 World Health Organiza ...... ral Nervous System: a summary.
@en
P2093
P50
P1476
The 2016 World Health Organiza ...... ral Nervous System: a summary.
@en
P2093
Arie Perry
David N Louis
David W Ellison
Hiroko Ohgaki
Otmar D Wiestler
Paul Kleihues
Webster K Cavenee
P2888
P304
P356
10.1007/S00401-016-1545-1
P577
2016-05-09T00:00:00Z
P6179
1021788062